Substituted piperidines as melanocortin receptor agonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/12 (2006.01) A61K 31/496 (2006.01) A61P 15/10 (2006.01) C07D 401/14 (2006.01) C07D 413/14 (2006.01) C07D 487/08 (2006.01)

Patent

CA 2403686

Certain novel substituted piperidine compounds are agonists of the human melanocortin receptor(s) and, in partic-ular, are selective agonists of the human melanocortin-4 receptor (MC- 4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.

L'invention concerne des composés de pipéridine substituée qui sont des agonistes du récepteur(s) de la mélanocortine humaine et qui sont, en particulier, des agonistes sélectifs du récepteur de la mélanocortine-4 humaine (MC-4R). Il sont donc utiles pour le traitement, la lutte contre ou la prévention de maladies et de troubles sensibles à l'activation du récepteur MC-4R, tels que l'obésité, les diabètes, le dysfonctionnement sexuel, y compris les dysfonctionnements érectile et sexuel féminin.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted piperidines as melanocortin receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted piperidines as melanocortin receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted piperidines as melanocortin receptor agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1431443

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.